Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic

Clinical Therapeutics

Volumn 26, Issue 9, 2004, Pages 1470-1478

  Abdelhafiz, Ahmed H ^a   Wheeldon, Nigel M ^b,c  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c PEKING UNIVERSITY   (China)

Author keywords

anticoagulation; atrial fibrillation; bleeding complications; clinical practice

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISTAXIS; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HEART ATRIUM FIBRILLATION; HEMATOMA; HEMATURIA; HEMOPTYSIS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT CARE; PATIENT REFERRAL; PATIENT SELECTION; PHYSICIAN; PROSPECTIVE STUDY; RECTUM HEMORRHAGE; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; TELEPHONE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATTITUDE TO HEALTH; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; TREATMENT OUTCOME; WARFARIN;

EID: 9744241689     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.09.002     Document Type: Article

References (24)

1. [published correction appears in Arch Intern Med. 1994;154:2254] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized clinical trials Arch Intern Med 154 1994 1449 1457
2. Ezekowitz M.D., and Levine J.A. Preventing stroke in patients with atrial fibrillation JAMA 281 1999 1830 1835
3. Antani M.R., Beyth R.J., and Covinsky K.E. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation J Gen Intern Med 11 1996 713 720
4. Wheeldon N.M., Tayler D.I., and Anagnostou E. Screening for atrial fibrillation in primary care Heart 79 1998 50 55
5. Stroke prevention in atrial fibrillation study Final results Circulation 84 1991 527 539
6. Rosendaal F.R., Cannegieter S.C., van der Meer F.M., and Briët E. A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
7. [published correction appears in Arch Intern Med. 1992;152:825] Lancaster T.R., Singer D.E., and Sheehan M.A. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial Arch Intern Med 151 1991 1944 1949
8. Fihn S.D., Callahan C.M., and Martin D.C. National Consortium of Anticoagulation Clinics The risk for and severity of bleeding complications in elderly patients treated with warfarin Ann Intern Med 124 1996 970 979
9. O'Reilly R.A., Trager W.E., Rettie A.E., and Goulart D.A. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans Clin Pharmacol Ther 42 1987 290 294
10. Cohen N., Almoznino-Sarafian D., and Alon I. Warfarin for stroke prevention still underused in atrial fibrillation: Patterns of omission Stroke 31 2000 1217 1222
11. Kalra L., Yu G., and Perez I. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness BMJ 320 2000 1236 1239
12. [published correction appears in CMAJ. 2000;162:973] Caro J.J., Flegel K.M., and Orejuela M.E. Anticoagulant prophylaxis against stroke in atrial fibrillation: Effectiveness in actual practice CMAJ 161 1999 493 497
13. Lesho E.P., Michaud E., and Asquith D. Do anticoagulation clinics treat patients more effectively than physicians? Arch Intern Med 160 2000 243
14. Hellemons B.S., Langenberg M., and Lodder J. Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation in primary care: Ran domised controlled trial comparing two intensities of coumarin with aspirin BMJ 319 1999 958 964
15. Gullov A.L., Koefoed B.G., and Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: The AFASAK 2 study Arch Intern Med 159 1999 1322 1328
16. Di Carlo A., Launer L.J., Breteler M.M. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group Italian Longitudinal Study on Aging. Frequency of stroke in Europe: A collaborative study of population-based cohorts Neurology 54 Suppl 5 2000 S28 S33
17. Leckey R., Aguilar E.G., and Phillips S.J. Atrial fibrillation and the use of warfarin in patients admitted to an acute stroke unit Can J Cardiol 16 2000 481 485
18. Copland M., Walker I.D., and Tait R.C. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation Arch Intern Med 161 2001 2125 2128
19. [published correction appears in Drugs Aging. 1995;6:343] Beyth R.J., and Landefeld C.S. Anticoagulants in older patients. A safety perspective Drugs Aging 6 1995 45 54
20. Rosendaal F.R. The Scylla and Charybdis of oral anticoagulant treatment N Engl J Med 335 1996 587 589
21. The Stroke Prevention in Atrial Fibrillation Investigators Bleeding during antithrombotic therapy in patients with atrial fibrillation Arch Intern Med 156 1996 409 416
22. Landefeld C.S., and Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy Am J Med 87 1989 144 152
23. Howitt A., and Armstrong D. Implementing evidence based medicine in general practice: Audit and qualitative study of antithrombotic treatment for atrial fibrillation BMJ 318 1999 1324 1327
24. Quilliam B.J., and Lapane K.L. Clinical correlates and drug treatment of residents with stroke in long-term care Stroke 32 2001 1385 1393